{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:42Z","timestamp":1789603422453,"version":"build-2803163510"},"reference-count":222,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministry of Education and Merit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009886","name":"Puglia Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.07.020","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:48:25Z","timestamp":1784216905000},"page":"5760-5784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The polymeric nanovectors landscape for cancer immunotherapies towards advanced therapy medicinal products (ATMPs)"],"prefix":"10.1016","volume":"16","author":[{"given":"Ilaria Elena","family":"Palam\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Invidia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"De Stradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2058-0009","authenticated-orcid":false,"given":"Gabriella","family":"Leccese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Baldari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Quintarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Maiorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.07.020_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2026.07.020_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.apsb.2026.07.020_bib3","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2026.07.020_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/tde-2015-0003","article-title":"Nanocarrier-based co-delivery of small molecules and sirna\/mirna for treatment of cancer","volume":"7","author":"Chitkara","year":"2016","journal-title":"Ther Deliv"},{"key":"10.1016\/j.apsb.2026.07.020_bib5","article-title":"Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit","volume":"20","author":"Johanna","year":"2023","journal-title":"Immunooncol Technol"},{"key":"10.1016\/j.apsb.2026.07.020_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral vectors for gene therapy: translational and clinical outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.07.020_bib8","series-title":"Guide to cell therapy Gx","first-page":"15","article-title":"2\u2013European regulatory framework for the development of cell\u2013based medicines","author":"Cuende","year":"2016"},{"key":"10.1016\/j.apsb.2026.07.020_bib9","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.3390\/cancers14174160","article-title":"Tumor infiltrating lymphocyte (TIL) therapy for solid tumor treatment: progressions and challenges","volume":"14","author":"Zhao","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2026.07.020_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2217\/fon.12.125","article-title":"Dendritic cell\u2013based vaccines: barriers and opportunities","volume":"8","author":"Cintolo","year":"2012","journal-title":"Future Oncol"},{"key":"10.1016\/j.apsb.2026.07.020_bib11","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1039\/c2cs35094g","article-title":"Cationic polymers and their therapeutic potential","volume":"41","author":"Samal","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2026.07.020_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non\u2013viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.apsb.2026.07.020_bib13","article-title":"Polymeric nanocarriers for therapeutic gene delivery","volume":"20","author":"Zhang","year":"2025","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41587-019-0325-6","article-title":"Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency","volume":"38","author":"Nguyen","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/IJN.S229858","article-title":"Self-assembled nanoparticles prepared from low-molecular-weight PEI and low-generation pamam for EGFRVIII\u2013chimeric antigen receptor gene loading and T-cell transient modification","volume":"15","author":"Yu","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.07.020_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119418","article-title":"Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics","volume":"221","author":"Kim","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib17","doi-asserted-by":"crossref","first-page":"9963","DOI":"10.1016\/j.biomaterials.2014.08.036","article-title":"Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal\/immune cancer therapy","volume":"35","author":"Tao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/polym16081159","article-title":"Natural and synthetic polymers for biomedical and environmental applications","volume":"16","author":"Satchanska","year":"2024","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2026.07.020_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ab.2005.08.029","article-title":"Investigations of the effect of DNA size in transient transfection assay using dual luciferase system","volume":"346","author":"Yin","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.apsb.2026.07.020_bib20","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.nano.2015.04.015","article-title":"Size, surface charge, and shape determine therapeutic effects of nanoparticles on brain and retinal diseases","volume":"11","author":"Jo","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2026.07.020_bib21","series-title":"Natural polymer drug delivery systems","first-page":"95","article-title":"Natural polymers vs synthetic polymer","author":"Bhatia","year":"2016"},{"key":"10.1016\/j.apsb.2026.07.020_bib22","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/polym17162243","article-title":"Polymeric and polymer-functionalized drug delivery vectors: from molecular architecture and elasticity to cellular uptake","volume":"17","author":"Auth","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2026.07.020_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/156720112801323053","article-title":"Polymers and drug delivery systems","volume":"9","author":"Vilar","year":"2012","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.apsb.2026.07.020_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4155\/tde-2019-0044","article-title":"Polymeric nanoparticles as carrier for targeted and controlled delivery of anticancer agents","volume":"10","author":"Taghipour\u2013Sabzevar","year":"2019","journal-title":"Ther Deliv"},{"key":"10.1016\/j.apsb.2026.07.020_bib25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11095-007-9284-6","article-title":"Poly(ethylene glycol)-modified nanocarriers for tumor\u2013targeted and intracellular delivery","volume":"24","author":"van Vlerken","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jctb.4555","article-title":"Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy -future prospects","volume":"90","author":"Goodall","year":"2015","journal-title":"J Chem Technol Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib27","article-title":"Complicity of degradable polymers in health\u2013care applications","volume":"16","author":"Anju","year":"2020","journal-title":"Mater Today Chem"},{"key":"10.1016\/j.apsb.2026.07.020_bib28","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2026.07.020_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.020_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/elsc.202100040","article-title":"The pro-inflammatory response of macrophages regulated by acid degradation products of poly(lactide-co-glycolide) nanoparticles","volume":"21","author":"Ma","year":"2021","journal-title":"Eng Life Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jconrel.2023.09.001","article-title":"Polyethylenimine (PEI) in gene therapy: current status and clinical applications","volume":"362","author":"Casper","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.020_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/app.42096","article-title":"A review of the developments of characteristics of PEI derivatives for gene delivery applications","author":"Taranejoo","year":"2015","journal-title":"J Appl Polym Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib33","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/eji.201242410","article-title":"Enhancement of plasmid DNA immunogenicity with linear polyethylenimine","volume":"42","author":"Grant","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/CVI.00778-14","article-title":"H9N2 Influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice","volume":"22","author":"Qin","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nbt.2344","article-title":"Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens","volume":"30","author":"Wegmann","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib36","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1021\/acs.biomac.0c00614","article-title":"Metabolite-mased modification of poly(l-lysine) for improved gene delivery","volume":"21","author":"Urello","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2026.07.020_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bej.2012.04.001","article-title":"Review on production and medical applications of \u03b5\u2013polylysine","volume":"65","author":"Shukla","year":"2012","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.apsb.2026.07.020_bib38","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1038\/s41467-020-19651-7","article-title":"Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","article-title":"Prolonged activation of innate immune pathways by a polyvalent STING agonist","volume":"5","author":"Li","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib40","article-title":"Precise PBAEs: a highly efficient single-molecularly defined gene-delivery system","volume":"64","author":"Ma","year":"2025","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2026.07.020_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/btm2.10063","article-title":"Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine","volume":"2","author":"Andorko","year":"2017","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.apsb.2026.07.020_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","article-title":"PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy","volume":"12","author":"Abedi-Gaballu","year":"2018","journal-title":"Appl Mater Today"},{"key":"10.1016\/j.apsb.2026.07.020_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.msec.2017.02.163","article-title":"Targeted delivery of Bcl-2 conversion gene by MPEG-PCL-PEI-FA cationic copolymer to combat therapeutic resistant cancer","volume":"76","author":"Li","year":"2017","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.apsb.2026.07.020_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2026.07.020_bib45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2174\/0929867330666230316094540","article-title":"Multiple natural polymers in drug and gene delivery systems","volume":"31","author":"Jiang","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2026.07.020_bib46","series-title":"Chitin, chitosan, oligosaccharides and their derivatives","first-page":"357","article-title":"Chitosan-conjugated DNA nanoparticle delivery systems for gene therapy","author":"Jayakumar","year":"2010"},{"key":"10.1016\/j.apsb.2026.07.020_bib47","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/acsbiomaterials.2c01297","article-title":"Chitosan derivatives as carriers for drug delivery and biomedical applications","volume":"9","author":"Manna","year":"2023","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib48","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpb.2009.12.007","article-title":"Chitosan-modified poly(d,l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects","volume":"74","author":"Tahara","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.immuni.2016.03.002","article-title":"Chitosan: an adjuvant with an unanticipated STING","volume":"44","author":"Riteau","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.020_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS\u2013STING-dependent induction of type I interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.020_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biomaterials.2016.10.047","article-title":"Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine","volume":"113","author":"Shi","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.addr.2015.11.011","article-title":"Hyaluronic acid for anticancer drug and nucleic acid delivery","volume":"97","author":"Dosio","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.020_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133744","article-title":"Hyaluronic acid as a tumor progression agent and a potential chemotherapeutic biomolecule against cancer: a review on its dual role","volume":"275","author":"Gagneja","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2026.07.020_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fimmu.2014.00101","article-title":"Hyaluronan, a crucial regulator of inflammation","volume":"5","author":"Petrey","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib55","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/polym12081800","article-title":"Hyaluronic acid: the influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer","volume":"12","author":"Snetkov","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.apsb.2026.07.020_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2021.100869","article-title":"Cyclodextrin-based nanostructures","volume":"124","author":"Narayanan","year":"2022","journal-title":"Prog Mater Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202300106","article-title":"Anti-inflammatory nanotherapies based on bioactive cyclodextrin materials","volume":"3","author":"Li","year":"2023","journal-title":"Adv Nanobiomed Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib58","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2147\/IJN.S450205","article-title":"Regulating tumor-associated macrophage polarization by cyclodextrin-modified PLGA nanoparticles loaded with R848 for treating colon cancer","volume":"19","author":"Yuan","year":"2024","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.07.020_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120551","article-title":"Mannose-methyl-\u03b2-cyclodextrin suppresses tumor growth by targeting both colon cancer cells and tumor-associated macrophages","volume":"305","author":"Ohno","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.apsb.2026.07.020_bib60","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jddst.2017.10.021","article-title":"Size controlled fabrication of cellulose nanoparticles for drug delivery applications","volume":"43","author":"Chin","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.apsb.2026.07.020_bib61","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s10570-020-03674-w","article-title":"Cellulose and its derivatives: towards biomedical applications","volume":"28","author":"Seddiqi","year":"2021","journal-title":"Cellulose"},{"key":"10.1016\/j.apsb.2026.07.020_bib62","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.020_bib63","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1158\/1078-0432.CCR-17-1866","article-title":"Therapeutic immune modulation against solid cancers with intratumoral poly-ICLC: a pilot trial","volume":"24","author":"Kyi","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib64","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2147\/IJN.S222419","article-title":"Biodegradable polymers for gene-delivery applications","volume":"15","author":"Chen","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.07.020_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.020_bib66","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.7150\/thno.19365","article-title":"Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery","volume":"7","author":"An","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.07.020_bib67","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1021\/acsbiomaterials.3c01393","article-title":"Cell- and serum-derived proteins act as DAMPs to activate RAW 264.7 macrophage-like cells on silicone implants","volume":"10","author":"Blackman","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5135","article-title":"Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis","volume":"12","author":"Casulleras","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2026.07.020_bib69","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1208\/s12248-008-9065-0","article-title":"Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells","volume":"10","author":"Magadala","year":"2008","journal-title":"AAPS J"},{"key":"10.1016\/j.apsb.2026.07.020_bib70","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jconrel.2013.09.019","article-title":"Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research","volume":"172","author":"Elzoghby","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.020_bib71","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.3390\/nano11113002","article-title":"Amino acids, peptides, and proteins: implications for nanotechnological applications in biosensing and drug\/gene delivery","volume":"11","author":"Er","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib72","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/psc.2633","article-title":"Self-assembling amphiphilic peptides","volume":"20","author":"Dehsorkhi","year":"2014","journal-title":"J Pept Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib73","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/pharmaceutics16091112","article-title":"Increased cellular uptake of ApoE 3- or c(RGD)-modified liposomes for glioblastoma therapy depending on the target cells","volume":"16","author":"Lubitz","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.07.020_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106929","article-title":"Microfluidic post-insertion of polyethylene glycol lipids and KK or RGD high functionality and quality lipids in milk-derived extracellular vesicles","volume":"203","author":"Geng","year":"2024","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/srep10112","article-title":"Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes","volume":"5","author":"Nakase","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.07.020_bib76","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.1021\/nn401317t","article-title":"Lipid envelope-type nanoparticle incorporating a multifunctional peptide for systemic siRNA delivery to the pulmonary endothelium","volume":"7","author":"Kusumoto","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.020_bib77","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3389\/fimmu.2013.00491","article-title":"Dendritic cells: a spot on sialic acid","volume":"4","author":"Crespo","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib78","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acs.bioconjchem.8b00524","article-title":"mRNA polyplexes with post-conjugated GALA peptides efficiently target, transfect, and activate antigen presenting cells","volume":"30","author":"Lou","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.apsb.2026.07.020_bib79","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.gt.3300482","article-title":"In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes","volume":"4","author":"Li","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.apsb.2026.07.020_bib80","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/nano11061508","article-title":"Use of protamine in nanopharmaceuticals\u2014a review","volume":"11","author":"Ruseska","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib81","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.drudis.2021.01.004","article-title":"The role of the multifunctional antimicrobial peptide melittin in gene delivery","volume":"26","author":"Paray","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2026.07.020_bib82","series-title":"Polymeric nanoparticles as a promising tool for anti-cancer therapeutics","first-page":"389","article-title":"Conclusion and future prospective of polymeric nanoparticles for cancer therapy","author":"Shukla","year":"2019"},{"key":"10.1016\/j.apsb.2026.07.020_bib83","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2026.07.020_bib84","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1039\/c2cs35146c","article-title":"Branched and linear poly(ethylene imine)-based conjugates: synthetic modification, characterization, and application","volume":"41","author":"J\u00e4ger","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2026.07.020_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117820","article-title":"Enhancing non-viral gene delivery to human T cells through tuning nanoparticles physicochemical features, modulation cellular physiology, and refining transfection strategies","volume":"183","author":"Roustazadeh","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.07.020_bib86","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/10717544.2018.1510065","article-title":"Enhanced gene transfection efficiency by low-dose 25 kDa polyethylenimine by the assistance of 1.8 kDa polyethylenimine","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2026.07.020_bib87","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s11671-019-2882-5","article-title":"Improving magnetofection of magnetic polyethylenimine nanoparticles into MG-63 osteoblasts using a novel uniform magnetic field","volume":"14","author":"Cen","year":"2019","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.apsb.2026.07.020_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jgm.696","article-title":"Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis","volume":"7","author":"Akinc","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.apsb.2026.07.020_bib89","first-page":"345","article-title":"STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross\u2013presentation for cancer immunotherapy","volume":"42","author":"Nguyen","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejpb.2006.11.026","article-title":"A comparison of the effectiveness of cationic polymers poly-l-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC)","volume":"65","author":"Farrell","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib91","article-title":"Effects of dietary \u03b5-polylysine supplementation on growth performance, antioxidant capacity, immune function, and intestinal microbiota in growing male minks","volume":"16","author":"Wang","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.07.020_bib92","doi-asserted-by":"crossref","first-page":"42865","DOI":"10.1021\/acsami.9b12492","article-title":"Double-network nanogel as a nonviral vector for DNA delivery","volume":"11","author":"Ye","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.07.020_bib93","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/17425247.2020.1796628","article-title":"Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities","volume":"17","author":"Karlsson","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2026.07.020_bib94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijpharm.2013.11.027","article-title":"Gene delivery of PAMAM dendrimer conjugated with the nuclear localization signal peptide originated from fibroblast growth factor 3","volume":"459","author":"Lee","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400362","article-title":"Multifunctional PAMAM dendrimers carrying SAHA, 5-FU, and a therapeutic gene for targeted co-delivery toward colorectal cancer cells","volume":"19","author":"Bulkurcuo\u011flu","year":"2024","journal-title":"Biotechnol J"},{"key":"10.1016\/j.apsb.2026.07.020_bib96","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2023.06.027","article-title":"Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route","volume":"360","author":"Takata","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.020_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119792","article-title":"PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production","volume":"588","author":"Suzuki","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib98","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1021\/acs.bioconjchem.8b00237","article-title":"Polysarcosine as an alternative to PEG for therapeutic protein conjugation","volume":"29","author":"Hu","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.apsb.2026.07.020_bib99","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.apsb.2026.07.020_bib100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.020_bib101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biomaterials.2018.06.014","article-title":"Correlating quantitative tumor accumulation and gene knockdown using SPECT\/CT and bioluminescence imaging within an orthotopic ovarian cancer model","volume":"178","author":"Jones","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202000371","article-title":"Mannosylated cationic copolymers for gene delivery to macrophages","volume":"21","author":"Lopukhov","year":"2021","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.apsb.2026.07.020_bib103","first-page":"23","article-title":"Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment","volume":"1865","author":"Lahmar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.07.020_bib104","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10611860108997928","article-title":"Enhanced gene transfection in macrophages using mannosylated cationic liposome-polyethylenimine-plasmid DNA complexes","volume":"9","author":"Sato","year":"2001","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2026.07.020_bib105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/mp5005492","article-title":"Mannosylated polyion complexes for in vivo gene delivery into CD11c + dendritic cells","volume":"12","author":"Raviv","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib106","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-020-19486-2","article-title":"In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo","volume":"11","author":"Parayath","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202103258","article-title":"Nanocomplex-mediated in vivo programming to chimeric antigen receptor-M1 macrophages for cancer therapy","volume":"33","author":"Kang","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib108","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12951-023-01810-9","article-title":"Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2\/Her2-specific CAR-macrophages for brainstem glioma immunotherapy","volume":"21","author":"Gao","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib109","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.03.029","article-title":"Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma","volume":"229","author":"Xie","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.020_bib110","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1039\/D5NA00169B","article-title":"Synthesis, characterization, and evaluation of low molecular weight poly(\u03b2-amino ester) nanocarriers for enhanced T cell transfection and gene delivery in cancer immunotherapy","volume":"7","author":"Gharatape","year":"2025","journal-title":"Nanoscale Adv"},{"key":"10.1016\/j.apsb.2026.07.020_bib111","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1182\/bloodadvances.2020002355","article-title":"Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy","volume":"4","author":"Wilk","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.apsb.2026.07.020_bib112","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1166\/jbn.2019.2697","article-title":"Magnetic resonance imaging of the human ferritin heavy chain reporter gene carried by dendrimer-entrapped gold nanoparticles","volume":"15","author":"Zhuo","year":"2019","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib113","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/acs.biomac.4c01411","article-title":"Amphiphilic polyaspartamide derivatives with cholesterol introduction enhanced ex vivo mRNA transfection efficiency to natural killer cells","volume":"26","author":"Koam","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2026.07.020_bib114","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1021\/acsami.9b23084","article-title":"Reshaping tumor immune microenvironment through acidity-responsive nanoparticles featured with CRISPR\/Cas9-mediated programmed death-ligand 1 attenuation and chemotherapeutics-induced immunogenic cell death","volume":"12","author":"Tu","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.07.020_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114232","article-title":"Efficient polymeric nanoparticles for RNAi in macrophage reveal complex effects on polarization markers upon knockdown of STAT3\/STAT6","volume":"197","author":"Walther","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib116","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib117","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.actbio.2013.12.050","article-title":"Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells","volume":"10","author":"Heo","year":"2014","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2026.07.020_bib118","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.biomac.1c01571","article-title":"Genetic engineering of dendritic cells using partially zwitterionic dendrimer-entrapped gold nanoparticles boosts efficient tumor immunotherapy","volume":"23","author":"Ouyang","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2026.07.020_bib119","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301606120","article-title":"Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination","volume":"120","author":"Ben-Akiva","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.020_bib120","series-title":"Histology, T-cell lymphocyte","author":"Sauls","year":"2025"},{"key":"10.1016\/j.apsb.2026.07.020_bib121","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/rej.2023.0015","article-title":"T cell development and function","volume":"26","author":"Adu-Berchie","year":"2023","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib122","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri798","article-title":"T-cell development and the CD4\u2013CD8 lineage decision","volume":"2","author":"Germain","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib123","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40265-017-0690-8","article-title":"Chimeric antigen receptor (CAR) T cells: lessons learned from targeting of CD19 in B-cell malignancies","volume":"77","author":"Hay","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2026.07.020_bib124","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/PPO.0b013e31824d4465","article-title":"Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma","volume":"18","author":"Wu","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.apsb.2026.07.020_bib125","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.886637","article-title":"Influence of culture conditions on ex vivo expansion of T lymphocytes and their function for therapy: current insights and open questions","volume":"10","author":"Sudarsanam","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib126","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00262-013-1459-x","article-title":"Clinical-scale selection and viral transduction of human na\u00efve and central memory CD8+ T cells for adoptive cell therapy of cancer patients","volume":"62","author":"Casati","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.apsb.2026.07.020_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.apsb.2026.07.020_bib128","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2378543","article-title":"Approved CAR-T therapies have reproducible efficacy and safety in clinical practice","volume":"20","author":"Goyco Vera","year":"2024","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.apsb.2026.07.020_bib129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib130","article-title":"Injectable supramolecular hydrogels for in situ programming of Car-T cells toward solid tumor immunotherapy","volume":"36","author":"Zhu","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib131","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1021\/acsbiomaterials.0c00804","article-title":"Nanomaterials as smart immunomodulator delivery system for enhanced cancer therapy","volume":"6","author":"Yuan","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib132","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002308","article-title":"Nanoimmunotherapy: the smart trooper for cancer therapy","volume":"6","author":"Parveen","year":"2025","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.apsb.2026.07.020_bib133","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302425","article-title":"Engineering improved CAR T cell products with a multi-cytokine particle platform for hematologic and solid tumors","volume":"13","author":"Lin","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib135","first-page":"422","article-title":"Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles","volume":"34","author":"Yaman","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886429","article-title":"Next generation natural killer cells for cancer immunotherapy","volume":"13","author":"Rossi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib137","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12026-015-8664-y","article-title":"Practical NK cell phenotyping and variability in healthy adults","volume":"62","author":"Angelo","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib138","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.07.020_bib139","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib140","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.175.3.1636","article-title":"TLR7\/8-mediated activation of human NK cells results in accessory cell\u2013dependent IFN-\u03b3 production","volume":"175","author":"Hart","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib141","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2012.00335","article-title":"Human NK cell lytic granules and regulation of their exocytosis","volume":"3","author":"Krzewski","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.896228","article-title":"All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity","volume":"13","author":"Ram\u00edrez\u2013Labrada","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib143","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fimmu.2014.00305","article-title":"Baseline and dynamic expression of activating NK cell receptors in the control of chronic viral infections: the paradigm of HIV-1 and HCV","volume":"5","author":"Marras","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib144","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.coi.2012.01.001","article-title":"NK cell MHC class I specific receptors (KIR): from biology to clinical intervention","volume":"24","author":"Thielens","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltac003","article-title":"Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy","volume":"2","author":"Schmidt","year":"2022","journal-title":"Immunother Adv"},{"key":"10.1016\/j.apsb.2026.07.020_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611163","article-title":"Engineering NK cells for CAR therapy\u2014Recent advances in gene transfer methodology","volume":"11","author":"Schmidt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib147","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3390\/cells10123390","article-title":"NK cells armed with chimeric antigen receptors (CAR): roadblocks to successful development","volume":"10","author":"Bashiri Dezfouli","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.07.020_bib148","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40425-017-0275-9","article-title":"Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma","volume":"5","author":"Kremer","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2026.07.020_bib149","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3389\/fimmu.2019.00957","article-title":"Human CAR NK cells: a new non-viral method allowing high efficient transfection and strong tumor cell killing","volume":"10","author":"Ingegnere","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2016.00105","article-title":"Efficient mRNA-based genetic engineering of human NK cells with high-affinity CD16 and CCR7 augments rituximab-induced ADCC against lymphoma and targets NK cell migration toward the lymph node-associated chemokine CCL19","volume":"7","author":"Carlsten","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.741305","article-title":"Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib152","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies","volume":"41","author":"Kumari","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib153","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib154","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.2147\/IJN.S421173","article-title":"Macrophages as promising carriers for nanoparticle delivery in anticancer therapy","volume":"18","author":"Wr\u00f3blewska","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.07.020_bib155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-3155-12-5","article-title":"Engineered nanoparticles interacting with cells: size matters","volume":"12","author":"Shang","year":"2014","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121489","article-title":"Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity","volume":"284","author":"Xu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100993","article-title":"Revealing macropinocytosis using nanoparticles","volume":"83","author":"Means","year":"2022","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.apsb.2026.07.020_bib158","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12951-021-00863-y","article-title":"Phagocytosis of polymeric nanoparticles aided activation of macrophages to increase atherosclerotic plaques in ApoE\u2212\/\u2212 mice","volume":"19","author":"Yin","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib159","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib160","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.07.020_bib161","article-title":"Biomaterial strategies for targeted intracellular delivery to phagocytes","volume":"36","author":"Woodworth","year":"2025","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100127","article-title":"Nanoparticle internalization promotes the survival of primary macrophages","volume":"2","author":"Jarai","year":"2022","journal-title":"Adv Nanobiomed Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib163","article-title":"Advanced strategies to evade the mononuclear phagocyte system clearance of nanomaterials","volume":"3","author":"Lu","year":"2023","journal-title":"Explorations"},{"key":"10.1016\/j.apsb.2026.07.020_bib164","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biomaterials.2016.09.034","article-title":"Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment","volume":"112","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib165","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.01.064","article-title":"Carboxyl- and amino-functionalized polystyrene nanoparticles differentially affect the polarization profile of M1 and M2 macrophage subsets","volume":"85","author":"Fuchs","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib166","doi-asserted-by":"crossref","first-page":"19436","DOI":"10.1021\/acsami.8b04718","article-title":"Modulation of macrophage phenotype by biodegradable polyurethane nanoparticles: possible relation between macrophage polarization and immune response of nanoparticles","volume":"10","author":"Huang","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.07.020_bib167","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib168","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202201327","article-title":"Multifunctional liposomes remodeling tumor immune microenvironment for tumor chemoimmunotherapy","volume":"7","author":"Li","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.apsb.2026.07.020_bib169","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.nanolett.1c00209","article-title":"Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy","volume":"21","author":"Wei","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.07.020_bib170","doi-asserted-by":"crossref","first-page":"44407","DOI":"10.1021\/acsami.0c08473","article-title":"Nanoparticle delivery of MnO2 and antiangiogenic therapy to overcome hypoxia-driven tumor escape and suppress hepatocellular carcinoma","volume":"12","author":"Chang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.07.020_bib171","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jconrel.2023.07.009","article-title":"Macrophage-reprogramming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer","volume":"360","author":"Yoon","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.020_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106427","article-title":"Sialic acid-targeted cyclodextrin-based nanoparticles deliver CSF\u20131R siRNA and reprogram tumour-associated macrophages for immunotherapy of prostate cancer","volume":"185","author":"Sun","year":"2023","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib173","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41467-024-44941-9","article-title":"Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib174","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1016\/j.biomaterials.2011.03.067","article-title":"Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy","volume":"32","author":"Kwong","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib175","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1039\/C9NR03353J","article-title":"Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages","volume":"11","author":"Han","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.07.020_bib176","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stemcr.2022.12.012","article-title":"Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies","volume":"18","author":"Zhang","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.apsb.2026.07.020_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103873","article-title":"CAR-macrophage: an extensive immune enhancer to fight cancer","volume":"76","author":"Wang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2026.07.020_bib178","first-page":"1","article-title":"Dendritic cell subsets and locations","volume":"348","author":"Balan","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.apsb.2026.07.020_bib179","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41551-018-0250-x","article-title":"Towards superior dendritic-cell vaccines for cancer therapy","volume":"2","author":"Saxena","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","article-title":"Human inflammatory dendritic cells induce Th17 cell differentiation","volume":"38","author":"Segura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.020_bib181","first-page":"279","article-title":"Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation","volume":"5","author":"Chistiakov","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2026.07.020_bib182","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13046-024-03121-9","article-title":"Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling","volume":"43","author":"Monti","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.020_bib183","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3389\/fimmu.2019.02393","article-title":"Induction of tolerance and immunity by dendritic cells: mechanisms and clinical applications","volume":"10","author":"Fucikova","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib184","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.immuni.2009.08.027","article-title":"Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells","volume":"31","author":"Dorner","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.020_bib185","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2019.01014","article-title":"Beyond cDC 1: emerging roles of DC crosstalk in cancer immunity","volume":"10","author":"Noubade","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib186","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13720","article-title":"The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity","volume":"7","author":"Laoui","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib187","article-title":"FLT3L combined with GM-CSF induced dendritic cells drive broad tumor-specific CD8+ T cell responses and remodel the tumor microenvironment to enhance anti-tumor efficacy","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib188","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2297453","article-title":"Toll-like receptor agonists as cancer vaccine adjuvants","volume":"20","author":"Jeon","year":"2024","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.apsb.2026.07.020_bib189","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/s41467-019-13368-y","article-title":"Engineering dendritic cell vaccines to improve cancer immunotherapy","volume":"10","author":"Perez","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri2569","article-title":"Signalling through C-type lectin receptors: shaping immune responses","volume":"9","author":"Geijtenbeek","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib191","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib192","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.2147\/IJN.S66639","article-title":"Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma\u2013associated antigen","volume":"9","author":"Hanlon","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.07.020_bib193","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.02.034","article-title":"Polymeric nanoparticles encapsulating novel TLR7\/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy","volume":"164","author":"Kim","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib194","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.2147\/IJN.S318363","article-title":"Chitosan-poly(acrylic acid) nanoparticles loaded with R848 and MnCl2 inhibit melanoma via regulating macrophage polarization and dendritic cell maturation","volume":"16","author":"Liu","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2026.07.020_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10588","article-title":"Cancer vaccines in the clinic","volume":"9","author":"Janes","year":"2024","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.apsb.2026.07.020_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1213629","article-title":"Impaired function of dendritic cells within the tumor microenvironment","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib197","doi-asserted-by":"crossref","first-page":"27589","DOI":"10.1021\/acsami.8b02019","article-title":"Dendritic cell-targeted nanovaccine delivery system prepared with an immune-active polymer","volume":"10","author":"Rajput","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.07.020_bib198","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1435","article-title":"The evolutionary history of lymphoid organs","volume":"8","author":"Boehm","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.07.020_bib199","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s40820-023-01125-2","article-title":"Application of nano-delivery systems in lymph nodes for tumor immunotherapy","volume":"15","author":"Xia","year":"2023","journal-title":"Nano-Micro Lett"},{"key":"10.1016\/j.apsb.2026.07.020_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.apsb.2026.07.020_bib201","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/pharmaceutics14071372","article-title":"Nanomaterial-based drug delivery system targeting lymph nodes","volume":"14","author":"Cheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.07.020_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120208","article-title":"Lymph node-targeted immune-activation mediated by imiquimod-loaded mesoporous polydopamine based-nanocarriers","volume":"255","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2026.07.020_bib203","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/acs.nanolett.0c04783","article-title":"Engineering nanoscale artificial antigen\u2013presenting cells by metabolic dendritic cell labeling to potentiate cancer immunotherapy","volume":"21","author":"Xiao","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.07.020_bib204","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1080\/10717544.2022.2086941","article-title":"Phenylboronic ester-modified polymeric nanoparticles for promoting TRP2 peptide antigen delivery in cancer immunotherapy","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2026.07.020_bib205","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41467-018-03001-9","article-title":"Sustained micellar delivery via inducible transitions in nanostructure morphology","volume":"9","author":"Karabin","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.020_bib206","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2019.12.013","article-title":"Delivered antigen peptides to resident CD8\u03b1+ DCs in lymph node by micelle-based vaccine augment antigen-specific CD8+ effector T cell response","volume":"147","author":"Wang","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2026.07.020_bib207","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","article-title":"Programmable multistage drug delivery to lymph nodes","volume":"15","author":"Schudel","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.07.020_bib208","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/jemt.23728","article-title":"Structure of the Eurasian moorhen spleen: a comprehensive study using gross anatomy, light, and transmission electron microscopy","volume":"84","author":"Abdellatif","year":"2021","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.apsb.2026.07.020_bib209","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300351","article-title":"Recent advances of emerging spleen-targeting nanovaccines for immunotherapy","volume":"12","author":"He","year":"2023","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2026.07.020_bib210","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.07.020_bib211","doi-asserted-by":"crossref","first-page":"21321","DOI":"10.1021\/jacs.1c09822","article-title":"Zwitterionic phospholipidation of cationic polymers facilitates systemic mRNA delivery to spleen and lymph nodes","volume":"143","author":"Liu","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2026.07.020_bib212","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.07.020_bib213","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144365","article-title":"NKTR\u2013255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells","volume":"131","author":"Robinson","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.07.020_bib214","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/thoraxjnl-2021-217001","article-title":"Tumour-infiltrating bystander CD8+ T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer","volume":"77","author":"Leem","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.apsb.2026.07.020_bib215","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050725","article-title":"Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol","volume":"11","author":"Creemers","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.apsb.2026.07.020_bib216","doi-asserted-by":"crossref","first-page":"34","DOI":"10.21682\/2311-1267-2023-10-4-11-34-43","article-title":"Pilot clinical trial of DNA vaccination against neuroblastoma: study design and preliminary results","volume":"10","author":"Proleskovskaya","year":"2024","journal-title":"Ross J Pediatr Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.07.020_bib217","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.020_bib218","doi-asserted-by":"crossref","first-page":"v61","DOI":"10.1093\/neuonc\/noad179.0246","article-title":"CTIM\u201306. A phase 2 study of a novel immunotherapy sl-701 in adults with recurrent glioblastoma: exploring the prognostic value of treatment\u2013induced CD8+CD57+ T-cells as a marker for survival","volume":"25","author":"Peereboom","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.apsb.2026.07.020_bib219","article-title":"Dendritic cell vaccination in conjunction with a TLR agonist polarizes interferon immune responses in malignant glioma patients","author":"Prins","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.apsb.2026.07.020_bib220","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.3390\/ijms20236056","article-title":"Overcoming hurdles in nanoparticle clinical translation: the influence of experimental design and surface modification","volume":"20","author":"Shreffler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib221","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1039\/C8BM01262H","article-title":"Identifying key barriers in cationic polymer gene delivery to human T cells","volume":"7","author":"Olden","year":"2019","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2026.07.020_bib222","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact Mater"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:22:38Z","timestamp":1789600958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":222,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004570"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.020","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The polymeric nanovectors landscape for cancer immunotherapies towards advanced therapy medicinal products (ATMPs)","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}